DM Complications Flashcards

1
Q

Retinopathy Treatment

A

No specific drugs

Photocoagulation procedure may slow progression but doesn’t reverse established damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Retinopathy Prevention

A

Fundoscopic Exams
BP Control (<140/80)
Smoking Cessation
Glycemic control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fundoscopic Exams

A

T1: within 5 years post-diagnosis then yearly
T2: At diagnosis (once stable) then yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diabetic nephropathy Predictor/RF

A

Microalbuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Microalbuminuria Screening

A

T1: 5 years post-diagnosis
T2: At diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Urine Albumin Excretion

A

Random spot urine albumin/creatinine ratio

If positive, repeat test ~2-3 times in ~6 months (2/3 abnormal = diagnosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Normal 24 hr collection

A

<30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Normal Time collection

A

<20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MA 24 hr collection

A

30-299

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MA Time collection

A

20-199

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clinical albuminuria 24 hr collection

A

> 300

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical albuminuria time collection

A

> 200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prevention of Nephropathy

A

KEY!
Control HTN, lipids, and glucose
Smoking cessation
Annual assessment for microalbuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of Nephropathy

A

ACE-I/ARBs can slow progression and slightly reverse

Protein restriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Protein restriction guidelines

A
  1. 8-1.0 g/kg/d (gfr > 60)

0. 8 g/kg/day (gfr < 60)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Peripheral neuropathy

A

Reduced or loss sensation in LE
Painful neuropathies
Ranges from numbing, tingling, burning to lancinating pain
RF for foot ulcers and lower extremities amputation

17
Q

Diabetic Neuropathy

A

Peripheral neuropathy and GI/GU abnormalities

18
Q

Painful Neuropathies

A

Symptomatic relief via anticonvulsants/AEDs, antidepressants, capsaicin cream, NSAIDS/pain meds

19
Q

Anticonvulsants/Antiepileptic

A

Gabapentin
Pregabalin (Lyrica) (FDA)
Phenytoin
Carbamazepine

20
Q

Antidepressants

A

Tricyclic (TCAs): cheap

Duloxetine (Cymbalta): FDA, expensive

21
Q

Diabetic Foot Ulcers

A

Peripheral Neuropathy: sensation loss, change in pain threshold, unnoticed trauma, dry/brittle skin

22
Q

Diabetic Foot Ulcer Prevention

A

Glycemic and HTN control
Smoking cessation
Foot care and inspections

23
Q

Treatment of Diabetic Foot Ulcers

A
Increased duration bc of slow healing
Would debridement
Pressure relief
Oxygen therapy
Regranex gel
24
Q

Dyslipidemia in Diabetes

A

High TG and Low HDL

25
Q

Goals for dyslipidemia in Diabetes

A

HDL 40 (men)/ >50 (women)

26
Q

Statins

A

LDL reduction

Pts with CV disease or 40+ with >1 CVD risk factor

27
Q

Treatments of Elevated TGs

A

Fibric acid derivative: Gemfibrozil fenofibrate

Niacin!!!

28
Q

Treatment of Low HDL

A

Niacin!

Not with sever hyperglycemia

29
Q

Hypertension in Diabetes

A

Comorbidity of 20-60% of pts
Increases complications
Goal BP <140/80

30
Q

Treatment of HTN in DM

A

ACE-I
Thiazides (but increase glucose)
CCBs
Beta-blockers (reduce complications, mild negative on glycemic control, masks hypogl)

31
Q

ADA Treatment of HTN

A

ACE-I or ARB
+ Thiazide/amlodipine (gfr >30)
+ Lood diuretic (gfr <30)

More than one usually necessary

32
Q

Antiplatelet (aspirin) therapy

A

Secondary CHD prevention: everyone
Primary CHD Prevention: 50+ men, 60 + women & 1 or more CHD RF (family CHD, smoke, protein in urine, dyslipidemia, HTN)

75-160 mg daily